![Lyndra Therapeutics bags $13M Gates grant to develop once-monthly contraceptive pill | Fierce Biotech Lyndra Therapeutics bags $13M Gates grant to develop once-monthly contraceptive pill | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1564421743/20352616009_f37933f4f2_k.jpg/20352616009_f37933f4f2_k.jpg?VersionId=EyGoqcEsMEzYhqZG8hccMw4PEyOFt0Fw)
Lyndra Therapeutics bags $13M Gates grant to develop once-monthly contraceptive pill | Fierce Biotech
![Bill & Melinda Gates Foundation - Private Sector (including Foundations) - The Global Fund to Fight AIDS, Tuberculosis and Malaria Bill & Melinda Gates Foundation - Private Sector (including Foundations) - The Global Fund to Fight AIDS, Tuberculosis and Malaria](https://www.theglobalfund.org/media/6505/bill-melinda-gates-foundation-bill-gates-sue-desmond-hellmann-magbonini-insecticide-trial-field-site-arusha-tanzania.jpg)
Bill & Melinda Gates Foundation - Private Sector (including Foundations) - The Global Fund to Fight AIDS, Tuberculosis and Malaria
![Figure 3 from The Bill & Melinda Gates Foundation's grant-making programme for global health | Semantic Scholar Figure 3 from The Bill & Melinda Gates Foundation's grant-making programme for global health | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e3ebb7b42a71d1dcfad4e88de328ee0e51083cc2/7-Figure3-1.png)
Figure 3 from The Bill & Melinda Gates Foundation's grant-making programme for global health | Semantic Scholar
![Finnish deep tech company receives a grant from the Bill & Melinda Gates Foundation to create slow-release, long-acting injectable formulations for a human immunodeficiency virus (HIV) vaccine Finnish deep tech company receives a grant from the Bill & Melinda Gates Foundation to create slow-release, long-acting injectable formulations for a human immunodeficiency virus (HIV) vaccine](https://arcticstartup.com/wp-content/uploads/2023/03/delsitech-receives-grant-bill-melinda-gates.jpg)